However, the blockade of CTLA-4 is accompanied by excessive activity of T cells, which not only enhances anti-tumor immune response but can also results in serious clinical toxic side effects, such as autoimmune diseases in the digestive system, liver, skin, and the nervous system [109]. The gene discussed is CTLA4; the disease is neoplasm.